InvestorsHub Logo
Followers 17
Posts 1580
Boards Moderated 0
Alias Born 02/07/2007

Re: Cognition post# 3137

Wednesday, 06/04/2014 1:22:26 PM

Wednesday, June 04, 2014 1:22:26 PM

Post# of 8747
The FDA has to respond within 30 days of HALO asking for the removal which means we'll hear something in the next 10 days. When HALO announced the recommendation by the DMC on 5/13 to remove the clinical hold HALO stated they had also provided the info to the FDA asking for the removal. For all we know HALO provided the info prior to the DMC's vote. We could see the announcement at any time.

Code of Federal Regulations]Title 21
(e)Resumption of clinical investigations. An investigation may only resume after FDA (usually the Division Director, or the Director's designee, with responsibility for review of the IND) has notified the sponsor that the investigation may proceed. Resumption of the affected investigation(s) will be authorized when the sponsor corrects the deficiency(ies) previously cited or otherwise satisfies the agency that the investigation(s) can proceed. FDA may notify a sponsor of its determination regarding the clinical hold by telephone or other means of rapid communication. If a sponsor of an IND that has been placed on clinical hold requests in writing that the clinical hold be removed and submits a complete response to the issue(s) identified in the clinical hold order, FDA shall respond in writing to the sponsor within 30-calendar days of receipt of the request and the complete response. FDA's response will either remove or maintain the clinical hold, and will state the reasons for such determination. Notwithstanding the 30-calendar day response time, a sponsor may not proceed with a clinical trial on which a clinical hold has been imposed until the sponsor has been notified by FDA that the hold has been lifted.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HALO News